Clovis Oncology, Inc. CLVS

• REST ASSURED.. if a BO offer is announced, this MOFO will BREAK THRU $100… absolutely NO question of that.. shorts here are leveraged just like GME and AMC.. AND, they have WAY OVERSOLD the CALL options.. we are 1 TICK away from a CATACLYSMIC RUN on CLVS

• may be a stretch, but, a scenario exits where a gamma squeeze could blow this WAY PAST any BO offer, up to $100S

• in other words, a FAT ASS PAYDAY for us

• After debt holders are paid, imo, the BO will net $37 to $39 a share

• As with ANY BO negotiation, Sanofi probably came in a little low, between $2.75B - $4B. And, Pat wants AT LEAST $10B. So, the FINAL number will likely be in the ballpark of $6B… jmo

• SANOFI seeks to be a ONE STOP SHOP for cancer drugs. So, you can BET THE FARM they HAVE MADE AN OFFER here.

• ROUGHLY TRANSLATED.. BO TALKS WITH CLOVIS ARE ON THE TABLE FOR SANOFI..

PARIS – December 21, 2021 – Sanofi announced today that it has entered into an agreement to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company leveraging its proprietary, clinically validated XTEN® and innovative universal protease-releasable masking technology platform, Pro-XTENTM, to discover and develop transformative T-cell engagers (TCE) and cytokine therapies for patients with cancer.

• PREDICTION: AH BREAKOUT

• cant wait for the shorts here to LICK MY ASSHOLE clean, next week

• nothing more than daytrader exit, BITCHES